Gabriella Mariani
Fondazione IRCCS Istituto Nazionale dei Tumori(IT)University of Florence(IT)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies
Most-Cited Works
- → 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial(2007)1,506 cited
- → Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer(2005)618 cited
- → Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study(2022)369 cited
- → Spatial predictors of immunotherapy response in triple-negative breast cancer(2023)286 cited
- → Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives(2019)239 cited
- Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.(1985)